ArticleFrontiers in neurology2023

SARS-CoV-2-specific antibody responses following BNT162b2 vaccination in individuals with multiple sclerosis receiving different disease-modifying treatments.

Anastasia Lambrianides et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.